Literature DB >> 15665670

Effect of preservative-free artificial tears on the antimicrobial activity of human beta-defensin-2 and cathelicidin LL-37 in vitro.

Ling C Huang1, Daniele Jean, Alison M McDermott.   

Abstract

PURPOSE: Human beta-defensin-2 (hBD-2) and cathelicidin LL-37 are salt-sensitive cationic antimicrobial peptides expressed by ocular surface epithelia. The goal of this study was to investigate the effect of preservative-free artificial tears on hBD-2 and LL-37 antimicrobial activity against Pseudomonas aeruginosa.
METHODS: P. aeruginosa was incubated with hBD-2 or LL-37 in the absence or presence (70% vol/vol) of different preservative-free artificial tears--Visine Tears (300 mOsm/kg), Tears Naturale Free (261 mOsm/kg), TheraTears (185 mOsm/kg), and Refresh Plus (325 mOsm/kg)--for 2 hours at 37 degrees C. In some experiments, P. aeruginosa was incubated with hBD-2 or LL-37 and Visine Tears or Tears Naturale Free with or without carboxymethylcellulose (0.5% vol/vol final concentration). Plates were inoculated with samples of each reaction mixture and then incubated for 24 hours at 37 degrees C.
RESULTS: Visine Tears and Tears Naturale Free had little or no effect on the antimicrobial activity of 100 microg/mL hBD-2 or LL-37. In the presence of Refresh Plus and TheraTears, the activity of 100 microg/mL hBD-2 or LL-37 was reduced by 90% to 100%. Carboxymethylcellulose, at a concentration comparable to that present in Refresh Plus, reduced the effectiveness of hBD-2 or LL-37 by 40% to 90% in the presence of Tears Naturale Free and Visine Tears.
CONCLUSION: Human beta-defensin-2 and cathelicidin LL-37 inhibit the growth of P. aeruginosa in vitro, but this activity is markedly reduced in the presence of Refresh Plus and TheraTears. These results suggest that carboxymethylcellulose-containing artificial tears may reduce the activity of the endogenously produced antimicrobial peptides.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665670      PMCID: PMC1497875          DOI: 10.1097/01.icl.0000146320.64438.8c

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  36 in total

Review 1.  Structural features and biological activities of the cathelicidin-derived antimicrobial peptides.

Authors:  R Gennaro; M Zanetti
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

2.  Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells.

Authors:  Y V Chaly; E M Paleolog; T S Kolesnikova; I I Tikhonov; E V Petratchenko; N N Voitenok
Journal:  Eur Cytokine Netw       Date:  2000-06       Impact factor: 2.737

Review 3.  Antimicrobial peptides: properties and applicability.

Authors:  W van 't Hof; E C Veerman; E J Helmerhorst; A V Amerongen
Journal:  Biol Chem       Date:  2001-04       Impact factor: 3.915

4.  Effect of ions on antibacterial activity of human beta defensin 2.

Authors:  T Tomita; S Hitomi; T Nagase; H Matsui; T Matsuse; S Kimura; Y Ouchi
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

5.  Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium.

Authors:  D Tanaka; K T Miyasaki; R I Lehrer
Journal:  Oral Microbiol Immunol       Date:  2000-08

6.  Ocular surface epithelia express mRNA for human beta defensin-2.

Authors:  N A McNAMARA; R Van; O S Tuchin; S M Fleiszig
Journal:  Exp Eye Res       Date:  1999-11       Impact factor: 3.467

7.  Synergistic actions of antibacterial neutrophil defensins and cathelicidins.

Authors:  I Nagaoka; S Hirota; S Yomogida; A Ohwada; M Hirata
Journal:  Inflamm Res       Date:  2000-02       Impact factor: 4.575

8.  Human beta-defensin 2 is up-regulated during re-epithelialization of the cornea.

Authors:  A M McDermott; R L Redfern; B Zhang
Journal:  Curr Eye Res       Date:  2001-01       Impact factor: 2.424

9.  Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells.

Authors:  F Niyonsaba; A Someya; M Hirata; H Ogawa; I Nagaoka
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

10.  LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

Authors:  Q Chen; A P Schmidt; G M Anderson; J M Wang; J Wooters; J J Oppenheim; O Chertov
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  8 in total

Review 1.  Toll-like receptors and corneal innate immunity.

Authors:  Ashok Kumar; Fu-Shin X Yu
Journal:  Curr Mol Med       Date:  2006-05       Impact factor: 2.222

2.  The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears.

Authors:  A M McDermott; D Rich; J Cullor; M J Mannis; W Smith; T Reid; C J Murphy
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 3.  Role of host-defence peptides in eye diseases.

Authors:  Satya S Kolar; Alison M McDermott
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

Review 4.  Design of Membrane Active Peptides Considering Multi-Objective Optimization for Biomedical Application.

Authors:  Niels Röckendorf; Christian Nehls; Thomas Gutsmann
Journal:  Membranes (Basel)       Date:  2022-02-02

Review 5.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

6.  In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid.

Authors:  Ling C Huang; Rachel L Redfern; Srihari Narayanan; Rose Y Reins; Alison M McDermott
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

7.  Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems.

Authors:  Ndidi C Ngwuluka; Yahya E Choonara; Girish Modi; Lisa C du Toit; Pradeep Kumar; Leith Meyer; Tracy Snyman; Viness Pillay
Journal:  Parkinsons Dis       Date:  2017-04-26

8.  Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide.

Authors:  Guo-Xian Wei; Alexander N Campagna; Libuse A Bobek
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-11-11       Impact factor: 3.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.